|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
18.320 -0.100 (-0.543%) | 2022/12 - Final RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | 2018/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | -- | 2,579,774 | 3,222,413 | 2,950,105 |
| Net Cash from / (used in) Investing Activities | -- | -- | (4,706,229) | (171,962) | (5,244,915) |
| Net Cash from / (used in) Financing Activities | -- | -- | 1,467,129 | (1,935,979) | 3,137,535 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | -- | (659,326) | 1,114,472 | 842,725 |
| Cash & Cash Equivalents at beginning of period | -- | -- | 8,284,371 | 7,175,005 | 6,350,319 |
| Effect of Foreign Exchange Rate Changes | -- | -- | (300,164) | (5,106) | (18,039) |
| Others | -- | -- | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | -- | 7,324,881 | 8,284,371 | 7,175,005 |
| Remarks: | Real time quote last updated: 28/09/2023 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,783,642 |
| %Change | 14.814% |
| EPS / (LPS) | RMB 0.670 |
| NBV Per Share (¥) | RMB 16.996 |